Search in:

Expert Opinion on Investigational Drugs Volume 21, 2012 - Issue 8

Submit an article Journal homepage

263

Views

CrossRef citations to date

Altmetric

Key Paper Evaluation

More light at the end of the tunnel – apixaban in atrial fibrillation

Evaluation of Granger CB, Alexander JH, McMurray JJV et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011, 365:981-92 and Connolly SJ Eikelboom J, Joyner C et al. Apixaban in patients with atrial fibrillation. N Engl J Med 2011, 364:806-17.

Sheila A DoggrellQueensland University of Technology, School of Biomedical Sciences, Faculty of Health, Brisbane, GPO 2343, QLD 4002, Australia+ 61 7 3138 2015; + 61 7 3138 1534; [email protected]

, PhD DSc

Pages 1235-1239 | Published online: 13 Jun 2012

Cite this article
https://doi.org/10.1517/13543784.2012.696611

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (19)

Ermengol Sempere Verdú, Miguel Ángel Hernández Rodríguez, Isabel Barrio Díez & Óscar Esteban Jiménez. (2023) Los anticoagulantes orales directos (ACOD) no serían de primera elección en los pacientes frágiles con fibrilación auricular según los resultados de un nuevo ensayo clínico realizado en “condiciones reales”. Revista Clínica de Medicina de Familia.
Crossref

Karen Lipworth. (2023) Improving the Effectiveness of Anticoagulant Therapy: The Promise of Factor XI Inhibition. European Medical Journal, pages 18-29.
Crossref

Yu Zhi Pang, Deidre Anne De Silva, Sean Ng, Vinh Anh Huynh & Semra Ozdemir. (2023) Preferences for oral anticoagulant medications for managing atrial fibrillation. Annals of the Academy of Medicine, Singapore 52:6, pages 324-326.
Crossref

Ion Alexandru Cristian, Liviu Ionut Serbanoiu, Stefan Sebastian Busnatu, Valentin Chioncel & Catalina Liliana Andrei. (2022) The Impact of Antithrombotic Therapy in Patients with De-compensated Heart Failure and Iron. Balneo and PRM Research Journal 13:Vol.13, no.3, pages 512.
Crossref

A. CAPIAU, M. GRYMONPREZ, T. DE BACKER, S. GEVAERT, K. BOUSSERY & L. LAHOUSSE. (2021) Voorkamerfibrillatie en niet-vitamine K-antagonist orale anticoagulantia: van klinische studies tot gebruik in de dagelijkse praktijk. Tijdschrift voor Geneeskunde.
Crossref

Wen Jun Tiew, Vivien LX Wong, Vern Hsen Tan, Yong Chuan Tan & Elena MS Lee. (2020) A Real-world Experience of the Safety and Efficacy of Non-vitamin K Oral Anticoagulants Versus Warfarin in Patients with Non-valvular Atrial Fibrillation— A Single-centre Retrospective Cohort Study in Singapore. Annals of the Academy of Medicine, Singapore 49:11, pages 838-847.
Crossref

Dagmara Wojtowicz, Anna Tomaszuk-Kazberuk, Jolanta Małyszko & Marek Koziński. (2020) HEMATURIA AND OTHER KINDS OF BLEEDINGS ON NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION: AN UPDATED OVERVIEW ON OCCURRENCE, PATHOMECHANISMS AND MANAGEMENT. Wiadomości Lekarskie 73:11, pages 2528-2534.
Crossref

Elvina Ramisovna Kadyseva, Albina Zaynutdinovna Nigmedzyanova, Lyudmila Yurievna Kulagina & Maksim Leonidovich Maksimov. (2020) Clinical use of direct oral anticoagulants in modern practice. Efficiency and safety. Vrač skoroj pomoŝi (Emergency Doctor):11, pages 26-36.
Crossref

Karine Raquel Uhdich Kleibert, Emelli Fin Hermann, Paula Lorenzoni Nunes, Aline Schneider, Eniva Miladi Fernandes Stumm & Christiane de Fátima Colet. (2020) Polimedicação em usuários de varfarina sódica do Sistema Único de Saúde e variáveis associadas. REVISTA CIÊNCIAS EM SAÚDE 10:2, pages 28-35.
Crossref

C. James Watson, Sara Zettervall, Matthew Hall & Michael Ganetsky. (2019) Difficult Intraoperative Heparinization Following Andexanet Alfa Administration. Clinical Practice and Cases in Emergency Medicine 3:4, pages 390-394.
Crossref

Roland Diel & Niklas Lampenius. (2019) Cost-benefit analysis of VKA versus NOAC treatment in German patients with atrial fibrillation utilizing patient self-testing. Journal of Health Economics and Outcomes Research 6:3, pages 142-159.
Crossref

Pierluigi Merella, Giovanni Lorenzoni, Alessandro P. Delitala, Filomena Sechi, Federica Decandia, Graziana Viola, Paola Berne, Gianluca Deiana, Patrizio Mazzone & Gavino Casu. (2019) Left Atrial Appendage Occlusion in High Bleeding Risk Patients. Journal of Interventional Cardiology 2019, pages 1-7.
Crossref

T B Kondratieva, L V Popova & I N Bokarev. (2017) Non-vitamin K antagonist oral anticoagulants for heart diseases. Terapevticheskii arkhiv 89:9, pages 120-127.
Crossref

Yazid Aoudia, Thitima Kongnakorn, Evie Merinopoulou, Mohamed Said Bettayeb & Sid Ahmed Kherraf. (2017) Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria. Journal of Health Economics and Outcomes Research 5:1, pages 39-54.
Crossref

Ovidiu Vornicu, Anne-Sophie Larock, Jonathan Douxfils, François Mullier, Virginie Dubois, Maximilien Gourdin, Sarah Lessire & Anne-Sophie Dincq. (2016) Minimisation of Bleeding Risks Due to Direct Oral Anticoagulants. EMJ Hematology, pages 78-90.
Crossref

Wan Hui Wong, Christina YC Yip, Christina LL Sum, Chuen Wen Tan, Lai Heng Lee, Eng Soo Yap, Ponnudurai Kuperan, Wen Chang Ting & Heng Joo Ng. (2016) A Practical Guide to Ordering and Interpreting Coagulation Tests for Patients on Direct Oral Anticoagulants in Singapore. Annals of the Academy of Medicine, Singapore 45:3, pages 98-105.
Crossref

John Camm. (2015) International, Large-Scale, Real-World Clinical Data Confirm the Safety Profile of Rivaroxaban. EMJ Cardiology, pages 82-88.
Crossref

Ken Okumura, Hiroshi Inoue, Masahiro Yasaka, Juan Marcos Gonzalez, A. Brett Hauber, Bennett Levitan, Zhong Yuan & Jean Baptiste Briere. (2015) Japanese Patients’ and Physicians’ Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice Experiment. Journal of Health Economics and Outcomes Research 2:2, pages 207-220.
Crossref

Heng Joo Ng, Yen Lin Chee, Kuperan Ponnudurai, Lay Cheng Lim, Daryl Tan, Jam Chin Tay, Pankaj Kumar Handa, Mufeedha Akbar Ali & Lai Heng Lee. (2013) Consensus Recommendations for Preventing and Managing Bleeding Complications Associated with Novel Oral Anticoagulants in Singapore. Annals of the Academy of Medicine, Singapore 42:11, pages 593-602.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

More light at the end of the tunnel – apixaban in atrial fibrillation

Evaluation of Granger CB, Alexander JH, McMurray JJV et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011, 365:981-92 and Connolly SJ Eikelboom J, Joyner C et al. Apixaban in patients with atrial fibrillation. N Engl J Med 2011, 364:806-17.

Articles from other publishers (19)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

More light at the end of the tunnel – apixaban in atrial fibrillation

Evaluation of Granger CB, Alexander JH, McMurray JJV et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011, 365:981-92 and Connolly SJ Eikelboom J, Joyner C et al. Apixaban in patients with atrial fibrillation. N Engl J Med 2011, 364:806-17.

Citations (19)

Articles from other publishers (19)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date